EA Pharma Co., Ltd. promotes drug discovery and clinical development targeting IBD (Inflammatory Bowel Disease) and a wide range of other gastrointestinal diseases to launch new drugs and treatment methods that can provide solutions to unmet medical needs.
EA Pharma Co., Ltd. filed patent application 201648011868 that is titled SULFONAMIDE DERIVATIVE. This patent application has been granted as Patent Number 312805.
The invention covers Chemical compounds. The invention provides a sulfonamide derivative of a specific chemical structure that has terminal sulfonamide groups having, as substituents, phenyl groups or heterocyclic groups with heteroatoms as constituent elements, or a pharmaceutically acceptable salt thereof. These compounds are novel compounds having excellent alpha4-integrin-inhibiting activity.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act, wherein the examiner stated that the Claim(s) (1-4) are statutorily non-patentable and does not result in the enhancement of the known efficacy of that substance.
As a response, the Applicant humbly submits that the compound of general formula IIb as disclosed in the present invention is novel and has not been disclosed anywhere before. The same has also been acknowledged by the examiner of Patents in first examination report.
As a response, the Applicant humbly submits Scientific and Technical arguments.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
